SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Stabilisation Notice

26 Oct 2016 07:00

RNS Number : 4526N
ConvaTec Group PLC
26 October 2016
Β 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

ConvaTec Group plc (the "Company")

Stabilisation Notice

26 October 2016

Goldman Sachs International (contact: Craig Loftus; telephone: +44 (0)20 7774 1000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052.

The securities:

Issuer:

ConvaTec Group plc

Securities:

Ordinary shares ("ORDs") of the Issuer (ISIN: GB00BD3VFW73)

Offering size:

659,734,996

Offer price:

225p

Stabilisation:

Stabilising Manager:

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Stabilisation period expected to start on:

26 October 2016 at 8:00am

Stabilisation period expected to end no later than:

25 November 2016 (close of business)

Maximum size of over-allotment facility:

15% of global offer

Trading venue where stabilisation may be undertaken:

London Stock Exchange

Over-allotment Option:

Terms:

The Over-allotment Shareholders have granted Goldman Sachs International, in its capacity as Stabilising Manager and for the account of the underwriters, the option to acquire up to an additional 98,960,249 ORDs at the Offer price.

Duration:

This option may be executed at any time during the stabilisation period.

Β 

Disclaimer

Β 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

Β 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

Β 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

Β 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. The distribution of this announcement in other jurisdictions may be restricted by law, and persons whose possession this announcement comes into should inform themselves about, and observe, such restrictions.

Β 

END

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STAPGGPAUUPQUUQ
Date   Source Headline
30th Nov 20203:45 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:30 pmRNSTotal Voting Rights
30th Oct 202010:40 amRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
20th Oct 20204:05 pmRNSDirector/PDMR Shareholding
19th Oct 20203:30 pmRNSDirector/PDMR Shareholding
12th Oct 20202:00 pmRNSHolding(s) in Company
7th Oct 202011:50 amRNSDirector Declaration
5th Oct 20206:35 pmRNSHolding(s) in Company
29th Sep 20202:05 pmRNSScrip Dividend - Total Issued Shares
10th Sep 20201:00 pmRNSScrip Dividend - Calculation Price
28th Aug 20203:54 pmRNSDirector/PDMR Shareholding
28th Aug 20203:42 pmRNSDirector/PDMR Shareholding
11th Aug 20209:40 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSInterim Results
13th Jul 202011:00 amRNSNon-Executive Director appointment
30th Jun 20207:00 amRNSBoard Committee Changes
10th Jun 202010:00 amRNSHolding(s) in Company
1st Jun 202010:45 amRNSTotal Voting Rights
29th May 202010:00 amRNSBoard Change
19th May 202010:40 amRNSDirector/PDMR Shareholding
19th May 202010:35 amRNSDirector/PDMR Shareholding
18th May 20204:30 pmRNSHolding(s) in Company
14th May 202010:45 amRNSHolding(s) in Company
11th May 20204:10 pmRNSNon-Executive Director appointment
7th May 20204:15 pmRNSResult of AGM
5th May 20202:15 pmRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSConvaTec Group Plc Q1 2020 Trading Update
28th Apr 20202:20 pmRNSScrip Dividend - Total Issued Shares
22nd Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202012:30 pmRNSScrip Dividend - Calculation Price
3rd Apr 202011:00 amRNSDirector Declaration
2nd Apr 202012:45 pmRNSAnnual General Meeting Update
24th Mar 20202:20 pmRNSDirector Declaration
16th Mar 20203:40 pmRNS2019 Annual Report & Accounts and Notice of AGM
13th Mar 202011:05 amRNSDirector/PDMR Shareholding
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
11th Mar 20203:45 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSPreliminary Results
27th Feb 202011:00 amRNSNon-Executive Director appointment
10th Jan 202012:45 pmRNSDirector/PDMR Shareholding
7th Nov 20192:00 pmRNSUpdate Statement following AGM Voting Outcome
1st Nov 201911:30 amRNSTotal Voting Rights
30th Oct 20197:00 amRNSQ3 Trading Update
21st Oct 20194:50 pmRNSDirector/PDMR Shareholding
21st Oct 20193:45 pmRNSHolding(s) in Company
14th Oct 20193:30 pmRNSDirector/PDMR Shareholding
4th Oct 20197:30 amRNSDirector/PDMR Shareholding
27th Sep 20194:44 pmRNSScrip Dividend - Total Issued Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.